Literature DB >> 2997196

Functional activation of beta-adrenergic receptors by thiols in the presence or absence of agonists.

S E Pedersen, E M Ross.   

Abstract

Treatment of beta-adrenergic receptor with dithiothreitol (DTT) or other thiol compounds caused its functional activation in the presence or absence of agonist ligands. Such activation was observed in reconstituted unilamellar phospholipid vesicles that contained beta-adrenergic receptors, purified to greater than or equal to 95% homogeneity from turkey erythrocyte plasma membranes, and the stimulatory GTP-binding protein of the adenylate cyclase system (Gs) purified from rabbit liver. Incubation of the vesicles with 2-10 mM DTT at 0 degrees C for 1 h increased the rate (4-5-fold) and the extent (3-4-fold) of activation of Gs by guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding, an effect about equivalent to the addition of beta-adrenergic agonists. Treatment with DTT also markedly potentiated the ability of agonists to stimulate GTP gamma S binding, increasing the initial rate about 10-fold. DTT treatment was as effective as agonist in stimulating GTPase activity, and maximal stimulation was obtained when DTT-treated vesicles were assayed in the presence of agonist. Other thiol compounds produced effects similar to those of DTT but were at least 10-fold less potent. Stimulation of GTP gamma S binding or GTPase activity required active receptor, and treatment of the receptor with DTT prior to reconstitution also increased its efficacy. There was no effect of DTT on Gs alone. Thus, the site of action of DTT appears to be on the beta-adrenergic receptor itself, and the reduction of disulfides and the binding of agonist act synergistically to activate the receptor. DTT treatment made the receptor more labile to thermal denaturation. Inclusion of cholesterol or cholesteryl-hemisuccinate (5-25%) in the vesicles protected the reduced receptor against such denaturation and enhanced its recovery during reconstitution. No effect of cholesterol or cholesteryl-hemisuccinate was observed on the stability of the nonreduced receptor, which was comparable to that observed in native membranes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997196

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Role of H2O2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts.

Authors:  S Persad; V Panagia; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

3.  Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.

Authors:  T Costa; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  The avian beta-adrenergic receptor: primary structure and membrane topology.

Authors:  Y Yarden; H Rodriguez; S K Wong; D R Brandt; D C May; J Burnier; R N Harkins; E Y Chen; J Ramachandran; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Analysis of adenosine A₂a receptor stability: effects of ligands and disulfide bonds.

Authors:  Michelle A O'Malley; Andrea N Naranjo; Tzvetana Lazarova; Anne S Robinson
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

6.  Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin.

Authors:  S S Karnik; T P Sakmar; H B Chen; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Modulation of neutrophil migration by captopril.

Authors:  J G Elferink; B M de Koster
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

8.  Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.

Authors:  M F Divin; F A Bradbury; F I Carroll; J R Traynor
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

9.  Effect of thiols on beta 2-adrenoceptors in human mononuclear leucocytes.

Authors:  B Liebl; T Anhäupl; E Haen; J Remien
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

10.  Delineation of ligand binding and receptor signaling activities of purified P2Y receptors reconstituted with heterotrimeric G proteins.

Authors:  Erik T Bodor; Gary L Waldo; Rainer Blaesius; T Kendall Harden
Journal:  Purinergic Signal       Date:  2004-12       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.